{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:18:09Z","timestamp":1791670689044,"version":"4.3.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03098-y","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:49:01Z","timestamp":1743893341000},"page":"1045-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Left atrial appendage occlusion in patients with cancer"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5656-5571","authenticated-orcid":false,"given":"Nathaniel E.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Shabtaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"3098_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae222","author":"Q Chen","year":"2024","unstructured":"Chen Q, van Rein N, van der Hulle T, Heemelaar JC, Trines SA, Versteeg HH et al (2024) Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehae222","journal-title":"Eur Heart J"},{"key":"3098_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s11886-022-01769-3","volume":"24","author":"DL Madnick","year":"2022","unstructured":"Madnick DL, Fradley MG (2022) Atrial fibrillation and cancer patients: mechanisms and management. Curr Cardiol Rep 24:1517\u20131527. https:\/\/doi.org\/10.1007\/s11886-022-01769-3","journal-title":"Curr Cardiol Rep"},{"key":"3098_CR3","doi-asserted-by":"publisher","unstructured":"Vinter N, Christesen AMS, Fenger-Gr\u00f8n M, Tj\u00f8nneland A, Frost L Atrial fibrillation and risk of cancer: A Danish Population\u2010Based cohort study. J Am Heart Assoc 2018;7. https:\/\/doi.org\/10.1161\/JAHA.118.009543","DOI":"10.1161\/JAHA.118.009543"},{"key":"3098_CR4","doi-asserted-by":"publisher","first-page":"e102861","DOI":"10.1371\/journal.pone.0102861","volume":"9","author":"EB Ostenfeld","year":"2014","unstructured":"Ostenfeld EB, Erichsen R, Pedersen L, Farkas DK, Weiss NS, S\u00f8rensen HT (2014) Atrial fibrillation as a marker of occult cancer. PLoS ONE 9:e102861. https:\/\/doi.org\/10.1371\/journal.pone.0102861","journal-title":"PLoS ONE"},{"key":"3098_CR5","doi-asserted-by":"publisher","first-page":"e29929","DOI":"10.1016\/j.heliyon.2024.e29929","volume":"10","author":"W Huang","year":"2024","unstructured":"Huang W, Xu S, Zhou H, Ji W, Chen Y (2024) Global association of incidence between atrial fibrillation and the major Gastrointestinal cancers: an analysis based on the 2019 global burden of disease study. Heliyon 10:e29929. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29929","journal-title":"Heliyon"},{"key":"3098_CR6","doi-asserted-by":"publisher","unstructured":"Raposeiras Roub\u00edn S, Abu Assi E, Barreiro Pardal C, Cesp\u00f3n Fernandez M, Mu\u00f1oz Pousa I, Cobas Paz R et al (2020) New cancer diagnosis after bleeding in anticoagulated patients with atrial fibrillation. J Am Heart Assoc 9. https:\/\/doi.org\/10.1161\/JAHA.120.016836","DOI":"10.1161\/JAHA.120.016836"},{"key":"3098_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/20009666.2020.1726571","volume":"10","author":"N Lateef","year":"2020","unstructured":"Lateef N, Kapoor V, Ahsan MJ, Latif A, Ahmed U, Mirza M et al (2020) Atrial fibrillation and cancer; Understanding the mysterious relationship through a systematic review. J Community Hosp Intern Med Perspect 10:127\u2013132. https:\/\/doi.org\/10.1080\/20009666.2020.1726571","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"3098_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8985273","volume":"2019","author":"M Yuan","year":"2019","unstructured":"Yuan M, Zhang Z, Tse G, Feng X, Korantzopoulos P, Letsas KP et al (2019) Association of cancer and the risk of developing atrial fibrillation: A systematic review and Meta-Analysis. Cardiol Res Pract 2019:1\u20139. https:\/\/doi.org\/10.1155\/2019\/8985273","journal-title":"Cardiol Res Pract"},{"key":"3098_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","volume":"103","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton DP, S\u00f8ndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J et al (2010) Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997\u20132006. Br J Cancer 103:947\u2013953. https:\/\/doi.org\/10.1038\/sj.bjc.6605883","journal-title":"Br J Cancer"},{"key":"3098_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F et al (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137:1959\u20131969. https:\/\/doi.org\/10.1182\/blood.2020007338","journal-title":"Blood"},{"key":"3098_CR11","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.bjc.6605599","volume":"102","author":"S Noble","year":"2010","unstructured":"Noble S, Pasi J (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 102:S2\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6605599","journal-title":"Br J Cancer"},{"key":"3098_CR12","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/cncr.33470","volume":"127","author":"D Pastori","year":"2021","unstructured":"Pastori D, Marang A, Bisson A, Menichelli D, Herbert J, Lip GYH et al (2021) Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study. Cancer 127:2122\u20132129. https:\/\/doi.org\/10.1002\/cncr.33470","journal-title":"Cancer"},{"key":"3098_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.amjcard.2017.11.027","volume":"121","author":"A Elbadawi","year":"2018","unstructured":"Elbadawi A, Elgendy IY, Ha LD, Baig B, Saad M, Adly H et al (2018) In-Hospital cerebrovascular outcomes of patients with atrial fibrillation and cancer (from the National inpatient sample Database). Am J Cardiol 121:590\u2013595. https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.027","journal-title":"Am J Cardiol"},{"key":"3098_CR14","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.18632\/oncotarget.24143","volume":"9","author":"W-S Hu","year":"2018","unstructured":"Hu W-S, Lin C-L (2018) Impact of atrial fibrillation on the development of ischemic stroke among cancer patients classified by CHA2DS2-VASc score-a nationwide cohort study. Oncotarget 9:7623\u20137630. https:\/\/doi.org\/10.18632\/oncotarget.24143","journal-title":"Oncotarget"},{"key":"3098_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11239-021-02570-9","volume":"53","author":"C-L Wang","year":"2022","unstructured":"Wang C-L, Wu VC-C, Tu H-T, Huang Y-T, Chen S-W, Chu P-H et al (2022) Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation. J Thromb Thrombolysis 53:633\u2013645. https:\/\/doi.org\/10.1007\/s11239-021-02570-9","journal-title":"J Thromb Thrombolysis"},{"key":"3098_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1055\/s-0043-1762596","volume":"50","author":"M Hellfritzsch","year":"2024","unstructured":"Hellfritzsch M, Henriksen JN, Holt MI, Grove EL (2024) Drug\u2013Drug interactions in the treatment of Cancer-Associated venous thromboembolism with direct oral anticoagulants. Semin Thromb Hemost 50:489\u2013498. https:\/\/doi.org\/10.1055\/s-0043-1762596","journal-title":"Semin Thromb Hemost"},{"key":"3098_CR17","doi-asserted-by":"publisher","unstructured":"Truong B, Hornsby L, Fox B, Chou C, Zheng J, Qian J Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and cancer: A target trial emulation from SEER-Medicare database. Cardiovasc Drugs Ther 2024. https:\/\/doi.org\/10.1007\/s10557-024-07589-7","DOI":"10.1007\/s10557-024-07589-7"},{"key":"3098_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.hrthm.2023.01.007","volume":"20","author":"J Saw","year":"2023","unstructured":"Saw J, Holmes DR, Cavalcante JL, Freeman JV, Goldsweig AM, Kavinsky CJ et al (2023) SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure. Heart Rhythm 20:e1\u201316. https:\/\/doi.org\/10.1016\/j.hrthm.2023.01.007","journal-title":"Heart Rhythm"},{"key":"3098_CR19","doi-asserted-by":"publisher","unstructured":"Ghodrati-Misek M, Schl\u00f6glhofer T, Gross C, Maurer A, Zimpfer D, Beitzke D et al (2022) Left atrial appendage occlusion in ventricular assist device patients to decrease thromboembolic events: A computer simulation study. Front Physiol 13. https:\/\/doi.org\/10.3389\/fphys.2022.1010862","DOI":"10.3389\/fphys.2022.1010862"},{"key":"3098_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3348\/kjr.2023.0173","volume":"24","author":"MJ Cha","year":"2023","unstructured":"Cha MJ, An D-G, Kang M, Kim HM, Kim S-W, Cho I et al (2023) Correct closure of the left atrial appendage reduces stagnant blood flow and the risk of thrombus formation: A Proof-of-Concept experimental study using 4D flow magnetic resonance imaging. Korean J Radiol 24:647. https:\/\/doi.org\/10.3348\/kjr.2023.0173","journal-title":"Korean J Radiol"},{"key":"3098_CR21","doi-asserted-by":"publisher","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM et al 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 2024;149. https:\/\/doi.org\/10.1161\/CIR.0000000000001193","DOI":"10.1161\/CIR.0000000000001193"},{"key":"3098_CR22","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","volume":"2","author":"DM Witt","year":"2018","unstructured":"Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J et al (2018) American society of hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv 2:3257\u20133291. https:\/\/doi.org\/10.1182\/bloodadvances.2018024893","journal-title":"Blood Adv"},{"key":"3098_CR23","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/fcp.12769","volume":"36","author":"L Lafaie","year":"2022","unstructured":"Lafaie L, Hodin S, Sa\u00efb S, Bin V, Bertoletti L, Delavenne X (2022) Tyrosine kinase inhibitors and direct oral anticoagulants: in vitro evaluation of drug\u2013drug interaction mediated by P-glycoprotein. Fundam Clin Pharmacol 36:860\u2013868. https:\/\/doi.org\/10.1111\/fcp.12769","journal-title":"Fundam Clin Pharmacol"},{"key":"3098_CR24","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1016\/j.ejps.2023.106507","volume":"188","author":"B Fang","year":"2023","unstructured":"Fang B, Jin S, Du W, Cai W (2023) Anlotinib and fruquintinib co-administrated with warfarin increases the risk of bleeding: studied from Pharmacokinetic and pharmacodynamic perspectives. Eur J Pharm Sci 188:106507. https:\/\/doi.org\/10.1016\/j.ejps.2023.106507","journal-title":"Eur J Pharm Sci"},{"key":"3098_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/00498254.2022.2118643","volume":"52","author":"A Hasegawa","year":"2022","unstructured":"Hasegawa A, Tsujiya Y, Ueda A, Yamamori M, Okamura N (2022) In vivo evaluation of Pharmacokinetic drug\u2013drug interactions between fluorinated pyrimidine anticancer drugs, 5-fluorouracil and Capecitabin, and an anticoagulant, warfarin. Xenobiotica 52:608\u2013612. https:\/\/doi.org\/10.1080\/00498254.2022.2118643","journal-title":"Xenobiotica"},{"key":"3098_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.athoracsur.2024.01.007","volume":"118","author":"MC von Wyler","year":"2024","unstructured":"von Wyler MC, Hui DS, Mehaffey JH, Malaisrie SC, Vardas PN, Gillinov AM et al (2024) The society of thoracic surgeons 2023 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg 118:291\u2013310. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.01.007","journal-title":"Ann Thorac Surg"},{"key":"3098_CR27","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","volume":"384","author":"RP Whitlock","year":"2021","unstructured":"Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M et al (2021) Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med 384:2081\u20132091. https:\/\/doi.org\/10.1056\/NEJMoa2101897","journal-title":"N Engl J Med"},{"key":"3098_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/SLA.0000000000000960","volume":"260","author":"O Mc Cormack","year":"2014","unstructured":"Mc Cormack O, Zaborowski A, King S, Healy L, Daly C, O\u2019Farrell N et al (2014) New-onset atrial fibrillation Post-surgery for esophageal and junctional cancer. Ann Surg 260:772\u2013778. https:\/\/doi.org\/10.1097\/SLA.0000000000000960","journal-title":"Ann Surg"},{"key":"3098_CR29","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/cancers13164012","volume":"13","author":"GC Semeraro","year":"2021","unstructured":"Semeraro GC, Meroni CA, Cipolla CM, Cardinale DM (2021) Atrial fibrillation after lung cancer surgery: prediction, prevention and anticoagulation management. Cancers (Basel) 13:4012. https:\/\/doi.org\/10.3390\/cancers13164012","journal-title":"Cancers (Basel)"},{"key":"3098_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/jcm9010037","volume":"9","author":"I Fabiani","year":"2019","unstructured":"Fabiani I, Colombo A, Bacchiani G, Cipolla CM, Cardinale DM, Incidence (2019) Management, prevention and outcome of Post-Operative atrial fibrillation in thoracic surgical oncology. J Clin Med 9:37. https:\/\/doi.org\/10.3390\/jcm9010037","journal-title":"J Clin Med"},{"key":"3098_CR31","doi-asserted-by":"publisher","first-page":"rjz298","DOI":"10.1093\/jscr\/rjz298","volume":"2019","author":"C Toale","year":"2019","unstructured":"Toale C, Jones J, Fitzmaurice GJ, Eaton D (2019) Left atrial appendage clipping as an adjunctive therapy in lung cancer surgery for patients with atrial fibrillation: a case report. J Surg Case Rep 2019:rjz298. https:\/\/doi.org\/10.1093\/jscr\/rjz298","journal-title":"J Surg Case Rep"},{"key":"3098_CR32","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1016\/j.heliyon.2022.e12662","volume":"9","author":"M Yang","year":"2023","unstructured":"Yang M, Chen M, Gong C-Q, Li W, Zhang P-P, Zhang R et al (2023) Left atrial appendage closure in patients with reversed chicken-wing morphology: anatomical features and procedural strategy. Heliyon 9:e12662. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12662","journal-title":"Heliyon"},{"key":"3098_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11239-021-02490-8","volume":"53","author":"X Lu","year":"2022","unstructured":"Lu X, Chen T, Liu G, Guo Y, Shi X, Chen Y et al (2022) Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation. J Thromb Thrombolysis 53:191\u2013201. https:\/\/doi.org\/10.1007\/s11239-021-02490-8","journal-title":"J Thromb Thrombolysis"},{"key":"3098_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.7863\/ultra.16.05070","volume":"36","author":"Z Chen","year":"2017","unstructured":"Chen Z, Bai W, Li C, Wang H, Tang H, Qin Y et al (2017) Left atrial appendage parameters assessed by Real-Time Three-Dimensional transesophageal echocardiography predict thromboembolic risk in patients with nonvalvular atrial fibrillation. J Ultrasound Med 36:1119\u20131128. https:\/\/doi.org\/10.7863\/ultra.16.05070","journal-title":"J Ultrasound Med"},{"key":"3098_CR35","doi-asserted-by":"publisher","unstructured":"Xu B, Du Y, Xu C, Sun Y, Peng F, Wang S et al (2021) Left atrial appendage morphology and local Thrombogenesis-Related blood parameters in patients with atrial fibrillation. J Am Heart Assoc 10. https:\/\/doi.org\/10.1161\/JAHA.120.020406","DOI":"10.1161\/JAHA.120.020406"},{"key":"3098_CR36","doi-asserted-by":"publisher","unstructured":"L\u00d3PEZ-M\u00cdNGUEZ R JR, FERN\u00c1NDEZ\u2010VEGAS C, MILL\u00c1N\u2010NU\u00d1EZ V, FUENTES\u2010CA\u00d1AMERO ME, NOGALES\u2010ASENSIO JM et al (2014) Anatomical classification of left atrial appendages in specimens applicable to CT imaging techniques for implantation of amplatzer cardiac plug. J Cardiovasc Electrophysiol 25:976\u2013984. https:\/\/doi.org\/10.1111\/jce.12429","DOI":"10.1111\/jce.12429"},{"key":"3098_CR37","doi-asserted-by":"publisher","unstructured":"Chen LY, Chung MK, Allen LA, Ezekowitz M, Furie KL, McCabe P et al Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: A scientific statement from the American heart association. Circulation 2018;137. https:\/\/doi.org\/10.1161\/CIR.0000000000000568","DOI":"10.1161\/CIR.0000000000000568"},{"key":"3098_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/europace\/euaa287","volume":"23","author":"KD Tiver","year":"2021","unstructured":"Tiver KD, Quah J, Lahiri A, Ganesan AN, McGavigan AD (2021) Atrial fibrillation burden: an update\u2014the need for a CHA2DS2-VASc-AFBurden score. EP Europace 23:665\u2013673. https:\/\/doi.org\/10.1093\/europace\/euaa287","journal-title":"EP Europace"},{"key":"3098_CR39","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.3390\/jcm13113236","volume":"13","author":"S Kommu","year":"2024","unstructured":"Kommu S, Sharma PP (2024) Subclinical atrial fibrillation: to anticoagulate or not?? J Clin Med 13:3236. https:\/\/doi.org\/10.3390\/jcm13113236","journal-title":"J Clin Med"},{"key":"3098_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF et al (2024) Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med 390:107\u2013117. https:\/\/doi.org\/10.1056\/NEJMoa2310234","journal-title":"N Engl J Med"},{"key":"3098_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2024.01.002","volume":"123","author":"G Boriani","year":"2024","unstructured":"Boriani G, Gerra L, Mei DA, Bonini N, Vitolo M, Proietti M et al (2024) Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: what decision making on anticoagulation after the NOAH and artesia trials? Eur J Intern Med 123:37\u201341. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.002","journal-title":"Eur J Intern Med"},{"key":"3098_CR42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N et al (2023) Anticoagulation with Edoxaban in patients with atrial High-Rate episodes. N Engl J Med 389:1167\u20131179. https:\/\/doi.org\/10.1056\/NEJMoa2303062","journal-title":"N Engl J Med"},{"key":"3098_CR43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV et al (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70:926\u2013938. https:\/\/doi.org\/10.1016\/j.jacc.2017.06.047","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.01.023","volume":"165","author":"M Verso","year":"2022","unstructured":"Verso M, Agnelli G, Munoz A, Connors JM, Sanchez O, Huisman M et al (2022) Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study. Eur J Cancer 165:136\u2013145. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.023","journal-title":"Eur J Cancer"},{"key":"3098_CR45","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.thromres.2024.109184","volume":"244","author":"H Uno","year":"2024","unstructured":"Uno H, Xiong H, Cronin C, Schrag D, Connors JM (2024) Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial. Thromb Res 244:109184. https:\/\/doi.org\/10.1016\/j.thromres.2024.109184","journal-title":"Thromb Res"},{"key":"3098_CR46","doi-asserted-by":"publisher","unstructured":"Ajabnoor AM, Parisi R, Zghebi SS, Ashcroft DM, Faivre-Finn C, Morris C et al (2023) Common cancer types and risk of stroke and bleeding in patients with nonvalvular atrial fibrillation: A Population\u2010Based study in England. J Am Heart Assoc 12. https:\/\/doi.org\/10.1161\/JAHA.123.029423","DOI":"10.1161\/JAHA.123.029423"},{"key":"3098_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2023.02.003","volume":"112","author":"MC Vedovati","year":"2023","unstructured":"Vedovati MC, Giustozzi M, Munoz A, Bertoletti L, Cohen AT, Klok FA et al (2023) Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. Eur J Intern Med 112:29\u201336. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.003","journal-title":"Eur J Intern Med"},{"key":"3098_CR48","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.3390\/jcm13216514","volume":"13","author":"D Zweiker","year":"2024","unstructured":"Zweiker D, Bergler-Klein J, Fiedler L, Toth GG, Achleitner R, Schratter A et al (2024) Left atrial appendage closure in atrial fibrillation patients with cancer. J Clin Med 13:6514. https:\/\/doi.org\/10.3390\/jcm13216514","journal-title":"J Clin Med"},{"key":"3098_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjcard.2023.06.068","volume":"202","author":"S Kumar","year":"2023","unstructured":"Kumar S, Yoon S, Milioglou I, Tashtish N, Farmakis I, Dallan LAP et al (2023) Left atrial appendage closure outcomes in patients with cancer at a single tertiary center. Am J Cardiol 202:176\u2013181. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.068","journal-title":"Am J Cardiol"},{"key":"3098_CR50","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/ccd.30629","volume":"101","author":"F Gallo","year":"2023","unstructured":"Gallo F, Ronco F, D\u2019Amico G, Della Rocca DG, Mazzone P, Bordignon S et al (2023) Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or Gastrointestinal bleeding: insights from the LOGIC (Left atrial appendage occlusion in patients with Gastrointestinal or intracranial bleeding) international multicenter registry. Catheter Cardiovasc Interv 101:1144\u20131153. https:\/\/doi.org\/10.1002\/ccd.30629","journal-title":"Catheter Cardiovasc Interv"},{"key":"3098_CR51","doi-asserted-by":"publisher","first-page":"13802","DOI":"10.3390\/ijerph192113802","volume":"19","author":"K Zieli\u0144ski","year":"2022","unstructured":"Zieli\u0144ski K, Praco\u0144 R, Konka M, Kruk M, K\u0119pka C, Trochimiuk P et al (2022) Incidence and predictors of clinically significant bleedings after transcatheter left atrial appendage closure. Int J Environ Res Public Health 19:13802. https:\/\/doi.org\/10.3390\/ijerph192113802","journal-title":"Int J Environ Res Public Health"},{"key":"3098_CR52","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.3390\/jcm9072295","volume":"9","author":"JR L\u00f3pez-M\u00ednguez","year":"2020","unstructured":"L\u00f3pez-M\u00ednguez JR, Nogales-Asensio JM, Infante De Oliveira E, Santos L, Ruiz-Salmer\u00f3n R, Arzamendi-Aizpurua D et al (2020) Major bleeding predictors in patients with left atrial appendage closure: the Iberian registry II. J Clin Med 9:2295. https:\/\/doi.org\/10.3390\/jcm9072295","journal-title":"J Clin Med"},{"key":"3098_CR53","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.amjcard.2017.04.046","volume":"120","author":"M Lempereur","year":"2017","unstructured":"Lempereur M, Aminian A, Freixa X, Gafoor S, Shakir S, Omran H et al (2017) Left atrial appendage occlusion in patients with atrial fibrillation and previous major Gastrointestinal bleeding (from the amplatzer cardiac plug multicenter Registry). Am J Cardiol 120:414\u2013420. https:\/\/doi.org\/10.1016\/j.amjcard.2017.04.046","journal-title":"Am J Cardiol"},{"key":"3098_CR54","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.3390\/jcm12247637","volume":"12","author":"W Kowalska","year":"2023","unstructured":"Kowalska W, Mitr\u0119ga K, Olma A, Podolecki T, Kalarus Z, Streb W (2023) Anticoagulants versus left atrial appendage occlusion in patients with atrial fibrillation and Co-Morbid thrombocytopenia. J Clin Med 12:7637. https:\/\/doi.org\/10.3390\/jcm12247637","journal-title":"J Clin Med"},{"key":"3098_CR55","doi-asserted-by":"publisher","unstructured":"Zhang X, Jin Q, Hu J, Kong D, Pan C, Chen D et al (2021) Impact of thrombocytopenia in patients with atrial fibrillation undergoing left atrial appendage occlusion: A Propensity-Matched comparison of 190 consecutive watchman implantations. Front Cardiovasc Med 8. https:\/\/doi.org\/10.3389\/fcvm.2021.603501","DOI":"10.3389\/fcvm.2021.603501"},{"key":"3098_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.thromres.2024.01.012","volume":"235","author":"G Drozdinsky","year":"2024","unstructured":"Drozdinsky G, Arad N, Spectre G, Livneh N, Poran I, Raanani P et al (2024) Anticoagulation in cancer patients with atrial fibrillation and grade 3\u20134 thrombocytopenia. Thromb Res 235:92\u201397. https:\/\/doi.org\/10.1016\/j.thromres.2024.01.012","journal-title":"Thromb Res"},{"key":"3098_CR57","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11239-021-02393-8","volume":"52","author":"N Livneh","year":"2021","unstructured":"Livneh N, Braeken D, Drozdinsky G, Gafter-Gvili A, Seelig J, Rozovski U et al (2021) Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy. J Thromb Thrombolysis 52:590\u2013596. https:\/\/doi.org\/10.1007\/s11239-021-02393-8","journal-title":"J Thromb Thrombolysis"},{"key":"3098_CR58","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/europace\/euac043","volume":"24","author":"MB Munir","year":"2022","unstructured":"Munir MB, Khan MZ, Darden D, Abideen Asad ZU, Osman M, Singh GD et al (2022) Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National inpatient sample of 62 980 procedures. EP Europace 24:1451\u20131459. https:\/\/doi.org\/10.1093\/europace\/euac043","journal-title":"EP Europace"},{"key":"3098_CR59","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1111\/jce.15682","volume":"33","author":"S Das","year":"2022","unstructured":"Das S, Lorente-Ros M, Wu L, Mehta D, Suri R (2022) Safety of left atrial appendage closure in heart failure patients. J Cardiovasc Electrophysiol 33:2578\u20132584. https:\/\/doi.org\/10.1111\/jce.15682","journal-title":"J Cardiovasc Electrophysiol"},{"key":"3098_CR60","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/17434440.2022.2141112","volume":"19","author":"M Zhao","year":"2022","unstructured":"Zhao M, Hou CR, Bai J, Post F, Walsleben J, Herold N et al (2022) Effect of congestive heart failure on safety and efficacy of left atrial appendage closure in patients with non-valvular atrial fibrillation. Expert Rev Med Devices 19:805\u2013814. https:\/\/doi.org\/10.1080\/17434440.2022.2141112","journal-title":"Expert Rev Med Devices"},{"key":"3098_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jchf.2021.01.009","volume":"9","author":"AY Lin","year":"2021","unstructured":"Lin AY, Dinatolo E, Metra M, Sbolli M, Dasseni N, Butler J et al (2021) Thromboembolism in heart failure patients in sinus rhythm. JACC Heart Fail 9:243\u2013253. https:\/\/doi.org\/10.1016\/j.jchf.2021.01.009","journal-title":"JACC Heart Fail"},{"key":"3098_CR62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jacc.2019.10.058","volume":"75","author":"CL Fanola","year":"2020","unstructured":"Fanola CL, Norby FL, Shah AM, Chang PP, Lutsey PL, Rosamond WD et al (2020) Incident heart failure and Long-Term risk for venous thromboembolism. J Am Coll Cardiol 75:148\u2013158. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.058","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR63","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/S0049-3848(16)30134-7","volume":"140","author":"O K\u00f6nigsbr\u00fcgge","year":"2016","unstructured":"K\u00f6nigsbr\u00fcgge O, Riedl J, Grilz E, Wiltschke C, Zielinski C, Pabinger I et al (2016) PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients. Thromb Res 140:S176. https:\/\/doi.org\/10.1016\/S0049-3848(16)30134-7","journal-title":"Thromb Res"},{"key":"3098_CR64","doi-asserted-by":"publisher","unstructured":"Kadowaki H, Akazawa H, Shindo A, Ueda T, Ishida J, Komuro I (2024) Shared and reciprocal mechanisms between heart failure and cancer \u2015 an emerging concept of heart-Cancer axis \u2015. Circ J 88. https:\/\/doi.org\/10.1253\/circj.CJ-23-0838.:CJ-23-0838","DOI":"10.1253\/circj.CJ-23-0838"},{"key":"3098_CR65","doi-asserted-by":"publisher","first-page":"123170","DOI":"10.1016\/j.lfs.2024.123170","volume":"358","author":"FA Bhat","year":"2024","unstructured":"Bhat FA, Khan S, Khan AS, Haque SE, Akhtar M, Najmi AK (2024) Cardio-oncological dialogue: Understanding the mechanistic correlation between heart failure and cancer. Life Sci 358:123170. https:\/\/doi.org\/10.1016\/j.lfs.2024.123170","journal-title":"Life Sci"},{"key":"3098_CR66","doi-asserted-by":"publisher","first-page":"e34185","DOI":"10.1097\/MD.0000000000034185","volume":"102","author":"V Jaiswal","year":"2023","unstructured":"Jaiswal V, Ang SP, Shrestha AB, Wajid Z, Endurance EO, Ayoobkhan FS et al (2023) Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis. Medicine 102:e34185. https:\/\/doi.org\/10.1097\/MD.0000000000034185","journal-title":"Medicine"},{"key":"3098_CR67","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","volume":"144","author":"D Lakkireddy","year":"2021","unstructured":"Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J et al (2021) Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): A randomized, controlled trial. Circulation 144:1543\u20131552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057063","journal-title":"Circulation"},{"key":"3098_CR68","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","volume":"145","author":"R Galea","year":"2022","unstructured":"Galea R, De Marco F, Meneveau N, Aminian A, Anselme F, Gr\u00e4ni C et al (2022) Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial. Circulation 145:724\u2013738. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057859","journal-title":"Circulation"},{"key":"3098_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.10.101","author":"D Lakkireddy","year":"2024","unstructured":"Lakkireddy D, Ellis CR, Thaler D, Swarup V, Gambhir A, Hermiller J et al (2024) 5-Year results from the AMPLATZER amulet left atrial appendage occluder randomized controlled trial. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.101","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR70","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaccao.2022.10.016","volume":"5","author":"SA Shabtaie","year":"2023","unstructured":"Shabtaie SA, Tan NY, Ward RC, Lewis BR, Yang EH, Holmes DR et al (2023) Left atrial appendage occlusion in patients with atrial fibrillation and cancer. JACC CardioOncol 5:203\u2013212. https:\/\/doi.org\/10.1016\/j.jaccao.2022.10.016","journal-title":"JACC CardioOncol"},{"key":"3098_CR71","doi-asserted-by":"publisher","unstructured":"Sommer RJ, Lamport R, Melanson D, Devellian C, Levine A, Cain CM et al Preclinical assessment of a novel conformable Foam-Based left atrial appendage closure device. Biomed Res Int 2021;2021. https:\/\/doi.org\/10.1155\/2021\/4556400","DOI":"10.1155\/2021\/4556400"},{"key":"3098_CR72","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.jcin.2021.08.060","volume":"14","author":"RJ Sommer","year":"2021","unstructured":"Sommer RJ, Kim JH, Szerlip M, Chandhok S, Sugeng L, Cain C et al (2021) Conformal left atrial appendage seal device for left atrial appendage closure. JACC Cardiovasc Interv 14:2368\u20132374. https:\/\/doi.org\/10.1016\/j.jcin.2021.08.060","journal-title":"JACC Cardiovasc Interv"},{"key":"3098_CR73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ccd.26782","volume":"89","author":"TR Betts","year":"2017","unstructured":"Betts TR, Leo M, Panikker S, Kanagaratnam P, Koa-Wing M, Davies DW et al (2017) Percutaneous left atrial appendage occlusion using different technologies in the united Kingdom: A multicenter registry. Catheter Cardiovasc Interv 89:484\u2013492. https:\/\/doi.org\/10.1002\/ccd.26782","journal-title":"Catheter Cardiovasc Interv"},{"key":"3098_CR74","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G, Chiang C en, Fargo R, Freedman B et al (2018) Antithrombotic therapy for atrial fibrillation. Chest 154:1121\u20131201. https:\/\/doi.org\/10.1016\/j.chest.2018.07.040","journal-title":"Chest"},{"key":"3098_CR75","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:755\u2013759. https:\/\/doi.org\/10.1016\/0003-4975(95)00887-X","journal-title":"Ann Thorac Surg"},{"key":"3098_CR76","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1093\/europace\/eux211","volume":"20","author":"E Caliskan","year":"2018","unstructured":"Caliskan E, Sahin A, Yilmaz M, Seifert B, Hinzpeter R, Alkadhi H et al (2018) Epicardial left atrial appendage atriclip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery. EP Europace 20:e105\u2013e114. https:\/\/doi.org\/10.1093\/europace\/eux211","journal-title":"EP Europace"},{"key":"3098_CR77","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jtcvs.2021.10.032","volume":"166","author":"Y Rhee","year":"2023","unstructured":"Rhee Y, Park SJ, Lee JW (2023) Epicardial left atrial appendage clip occlusion in patients with atrial fibrillation during minimally invasive cardiac surgery. J Thorac Cardiovasc Surg 166:468\u2013474. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.10.032","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3098_CR78","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/15569845221091998","volume":"17","author":"A Kiankhooy","year":"2022","unstructured":"Kiankhooy A, Liem B, Dunnington GH, Pierce C, Eisenberg SJ, Burk S et al (2022) Left atrial appendage ligation using the atriclip device: Single-Center study of device safety and efficacy. Innovations: Technol Techniques Cardiothorac Vascular Surg 17:209\u2013216. https:\/\/doi.org\/10.1177\/15569845221091998","journal-title":"Innovations: Technol Techniques Cardiothorac Vascular Surg"},{"key":"3098_CR79","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/europace\/euaa004","volume":"22","author":"RR Tilz","year":"2020","unstructured":"Tilz RR, Fink T, Bartus K, Wong T, Vogler J, Nentwich K et al (2020) A collective European experience with left atrial appendage suture ligation using the LARIAT\u2009+\u2009device. EP Europace 22:924\u2013931. https:\/\/doi.org\/10.1093\/europace\/euaa004","journal-title":"EP Europace"},{"key":"3098_CR80","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2014.03.057","volume":"64","author":"MJ Price","year":"2014","unstructured":"Price MJ, Gibson DN, Yakubov SJ, Schultz JC, Di Biase L, Natale A et al (2014) Early safety and efficacy of percutaneous left atrial appendage suture ligation. J Am Coll Cardiol 64:565\u2013572. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.057","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","volume":"62","author":"K Bartus","year":"2013","unstructured":"Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J et al (2013) Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation. J Am Coll Cardiol 62:108\u2013118. https:\/\/doi.org\/10.1016\/j.jacc.2012.06.046","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR82","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jacc.2008.03.067","volume":"52","author":"AS Kanderian","year":"2008","unstructured":"Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL (2008) Success of surgical left atrial appendage closure. J Am Coll Cardiol 52:924\u2013929. https:\/\/doi.org\/10.1016\/j.jacc.2008.03.067","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR83","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","volume":"150","author":"JS Healey","year":"2005","unstructured":"Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH et al (2005) Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 150:288\u2013293. https:\/\/doi.org\/10.1016\/j.ahj.2004.09.054","journal-title":"Am Heart J"},{"key":"3098_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes","year":"2014","unstructured":"Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK et al (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus Long-Term warfarin therapy. J Am Coll Cardiol 64:1\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR85","doi-asserted-by":"publisher","unstructured":"Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P et al Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation. JAMA 2014;312:1988. https:\/\/doi.org\/10.1001\/jama.2014.15192","DOI":"10.1001\/jama.2014.15192"},{"key":"3098_CR86","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","volume":"79","author":"JV Freeman","year":"2022","unstructured":"Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA et al (2022) Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation. J Am Coll Cardiol 79:1785\u20131798. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.047","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR87","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","volume":"16","author":"M Coylewright","year":"2023","unstructured":"Coylewright M, Holmes DR, Kapadia SR, Hsu JC, Gibson DN, Freeman JV et al (2023) DAPT is comparable to OAC following LAAC with WATCHMAN FLX. JACC Cardiovasc Interv 16:2708\u20132718. https:\/\/doi.org\/10.1016\/j.jcin.2023.08.013","journal-title":"JACC Cardiovasc Interv"},{"key":"3098_CR88","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","volume":"14","author":"LV Boersma","year":"2017","unstructured":"Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B et al (2017) Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm 14:1302\u20131308. https:\/\/doi.org\/10.1016\/j.hrthm.2017.05.038","journal-title":"Heart Rhythm"},{"key":"3098_CR89","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4244\/EIJV11I13A292","volume":"11","author":"A Tzikas","year":"2016","unstructured":"Tzikas A, Gafoor S, Meerkin D, Freixa X, Cruz-Gonzalez I, Lewalter T et al (2016) Left atrial appendage occlusion with the AMPLATZER amulet device: an expert consensus step-by-step approach. EuroIntervention 11:1512\u20131521. https:\/\/doi.org\/10.4244\/EIJV11I13A292","journal-title":"EuroIntervention"},{"key":"3098_CR90","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.hrthm.2019.09.018","volume":"17","author":"VLK Vuddanda","year":"2020","unstructured":"Vuddanda VLK, Turagam MK, Umale NA, Shah Z, Lakkireddy DR, Bartus K et al (2020) Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data. Heart Rhythm 17:374\u2013382. https:\/\/doi.org\/10.1016\/j.hrthm.2019.09.018","journal-title":"Heart Rhythm"},{"key":"3098_CR91","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.ijcha.2024.101585","volume":"56","author":"M Tinoco","year":"2025","unstructured":"Tinoco M, Echarte-Morales J, Guerreiro CE, \u00c1vila Gil EM, Caneiro-Queija B, Barreiro-P\u00e9rez M et al (2025) Short- and long-term outcomes of percutaneous left atrial appendage occlusion in cancer patients. IJC Heart Vasculature 56:101585. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101585","journal-title":"IJC Heart Vasculature"},{"key":"3098_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40959-023-00192-z","volume":"9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang Z, Almani MU, Soon-Shiong R, Liu B (2023) Utilization and short-term outcomes of percutaneous left atrial appendage occlusion in patients with cancer. Cardio-Oncology 9:39. https:\/\/doi.org\/10.1186\/s40959-023-00192-z","journal-title":"Cardio-Oncology"},{"key":"3098_CR93","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K, Piayda K, Praco\u0144 R, Jackson GG et al (2021) Predictors of Device-Related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol 78:297\u2013313. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.098","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR94","doi-asserted-by":"publisher","unstructured":"Sedaghat A, Vij V, Al-Kassou B, Gloekler S, Galea R, F\u00fcrholz M et al (2021) Device-Related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry. Circ Cardiovasc Interv 14. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.010195","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195"},{"key":"3098_CR95","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S et al (2018) Device-Related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 71:1528\u20131536. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.076","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR96","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN et al (2018) Device-Related thrombus after left atrial appendage closure. Circulation 138:874\u2013885. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"3098_CR97","doi-asserted-by":"publisher","unstructured":"Osama M, Naeem N, ahmed asmaa, Chuprun D, Depta J, Rao M Abstract 4140981: In-Hospital outcomes of left atrial appendage occlusion (LAAO) among patients with atrial fibrillation and hematological malignancy; insight from the National inpatient database (2015\u20132020). Circulation 2024;150. https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4140981","DOI":"10.1161\/circ.150.suppl_1.4140981"},{"key":"3098_CR98","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jacc.2024.05.067","volume":"84","author":"SW Reinhardt","year":"2024","unstructured":"Reinhardt SW, Gibson DN, Hsu JC, Kapadia SR, Yeh RW, Price MJ et al (2024) Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion. J Am Coll Cardiol 84:889\u2013900. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.067","journal-title":"J Am Coll Cardiol"},{"key":"3098_CR99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2408308","author":"OM Wazni","year":"2024","unstructured":"Wazni OM, Saliba WI, Nair DG, Marijon E, Schmidt B, Hounshell T et al (2024) Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2408308","journal-title":"N Engl J Med"},{"key":"3098_CR100","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.123.067312","volume":"149","author":"SR Kapadia","year":"2024","unstructured":"Kapadia SR, Krishnaswamy A, Whisenant B, Potluri S, Iyer V, Aragon J et al (2024) Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation. Circulation 149:734\u2013743. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067312","journal-title":"Circulation"},{"key":"3098_CR101","doi-asserted-by":"publisher","unstructured":"Sun A, Ren S, Xiao Y, Chen Y, Wang N, Li C et al (2022) Real-time 3D echocardiographic transilluminated imaging combined with artificially intelligent left atrial appendage measurement for atrial fibrillation interventional procedures. Front Physiol 13. https:\/\/doi.org\/10.3389\/fphys.2022.1043551","DOI":"10.3389\/fphys.2022.1043551"},{"key":"3098_CR102","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/jcm7110441","volume":"7","author":"R Morcos","year":"2018","unstructured":"Morcos R, Al Taii H, Bansal P, Casale J, Manam R, Patel V et al (2018) Accuracy of Commonly-Used imaging modalities in assessing left atrial appendage for interventional closure: review Article. J Clin Med 7:441. https:\/\/doi.org\/10.3390\/jcm7110441","journal-title":"J Clin Med"},{"key":"3098_CR103","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s10554-024-03248-y","volume":"40","author":"H Wang","year":"2024","unstructured":"Wang H, Ge L, Zhou H, Lu X, Yu Z, Peng P et al (2024) Radiomics prediction models of left atrial appendage hypercoagulability based on machine learning algorithms: an exploration about cardiac computed tomography angiography imaging. Int J Cardiovasc Imaging 40:2405\u20132415. https:\/\/doi.org\/10.1007\/s10554-024-03248-y","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03098-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T18:11:35Z","timestamp":1766686295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03098-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":103,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03098-y","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"28 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}